Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Ketamine independently modulated power and phase-coupling of theta oscillations in Sp4 hypomorphic mice.

Wang X, Pinto-Duarte A, Behrens MM, Zhou X, Sejnowski TJ.

PLoS One. 2018 Mar 7;13(3):e0193446. doi: 10.1371/journal.pone.0193446. eCollection 2018.

2.

Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role.

Porcelli S, Lee SJ, Han C, Patkar AA, Albani D, Jun TY, Pae CU, Serretti A.

J Mol Neurosci. 2018 Feb;64(2):273-286. doi: 10.1007/s12031-017-1016-8. Epub 2017 Dec 19.

PMID:
29260453
3.

Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: Relationship with SP transcription factors.

MacDowell KS, Pinacho R, Leza JC, Costa J, Ramos B, García-Bueno B.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):481-492. doi: 10.1016/j.pnpbp.2017.08.005. Epub 2017 Aug 10.

PMID:
28803924
4.

Characterization of spatio-temporal epidural event-related potentials for mouse models of psychiatric disorders.

Wang X, Pinto-Duarte A, Behrens MM, Zhou X, Sejnowski TJ.

Sci Rep. 2015 Oct 13;5:14964. doi: 10.1038/srep14964.

5.

Role played by the SP4 gene in schizophrenia and major depressive disorder in the Han Chinese population.

Chen J, He K, Wang Q, Li Z, Shen J, Li T, Wang M, Wen Z, Li W, Qiang Y, Wang T, Ji J, Wu N, Wang Z, Zhang B, Feng G, He L, Xu Y, Shi Y.

Br J Psychiatry. 2016 May;208(5):441-5. doi: 10.1192/bjp.bp.114.151688. Epub 2015 Oct 8.

PMID:
26450579
6.

Transcription factor SP4 phosphorylation is altered in the postmortem cerebellum of bipolar disorder and schizophrenia subjects.

Pinacho R, Saia G, Meana JJ, Gill G, Ramos B.

Eur Neuropsychopharmacol. 2015 Oct;25(10):1650-1660. doi: 10.1016/j.euroneuro.2015.05.006. Epub 2015 May 21.

7.

Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice.

Higa KK, Ji B, Buell MR, Risbrough VB, Powell SB, Young JW, Geyer MA, Zhou X.

Int J Neuropsychopharmacol. 2015 Jun 2;18(11):pyv063. doi: 10.1093/ijnp/pyv063.

8.

Phosphorylation of transcription factor specificity protein 4 is increased in peripheral blood mononuclear cells of first-episode psychosis.

Pinacho R, Saia G, Fusté M, Meléndez-Pérez I, Villalta-Gil V, Haro JM, Gill G, Ramos B.

PLoS One. 2015 Apr 27;10(4):e0125115. doi: 10.1371/journal.pone.0125115. eCollection 2015.

9.

GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.

Young JW, Kamenski ME, Higa KK, Light GA, Geyer MA, Zhou X.

Neuropsychopharmacology. 2015 Nov;40(12):2715-26. doi: 10.1038/npp.2015.120. Epub 2015 Apr 24.

10.

Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia.

Pinacho R, Valdizán EM, Pilar-Cuellar F, Prades R, Tarragó T, Haro JM, Ferrer I, Ramos B.

J Psychiatr Res. 2014 Nov;58:189-96. doi: 10.1016/j.jpsychires.2014.08.006. Epub 2014 Aug 19.

PMID:
25175639
11.

Phosphorylation of the transcription factor Sp4 is reduced by NMDA receptor signaling.

Saia G, Lalonde J, Sun X, Ramos B, Gill G.

J Neurochem. 2014 May;129(4):743-52. doi: 10.1111/jnc.12657. Epub 2014 Feb 12.

12.

Reduced expression of SP1 and SP4 transcription factors in peripheral blood mononuclear cells in first-episode psychosis.

Fusté M, Pinacho R, Meléndez-Pérez I, Villalmanzo N, Villalta-Gil V, Haro JM, Ramos B.

J Psychiatr Res. 2013 Nov;47(11):1608-14. doi: 10.1016/j.jpsychires.2013.07.019. Epub 2013 Aug 12.

PMID:
23941741
13.

Cannabinoids and schizophrenia: therapeutic prospects.

Robson PJ, Guy GW, Di Marzo V.

Curr Pharm Des. 2014;20(13):2194-204. Review.

PMID:
23829368
14.

Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia.

Ji B, Wang X, Pinto-Duarte A, Kim M, Caldwell S, Young JW, Behrens MM, Sejnowski TJ, Geyer MA, Zhou X.

PLoS One. 2013 Jun 18;8(6):e66327. doi: 10.1371/journal.pone.0066327. Print 2013.

15.

Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms.

Pinacho R, Villalmanzo N, Roca M, Iniesta R, Monje A, Haro JM, Meana JJ, Ferrer I, Gill G, Ramos B.

J Psychiatr Res. 2013 Jul;47(7):926-34. doi: 10.1016/j.jpsychires.2013.03.004. Epub 2013 Mar 27.

PMID:
23540600
16.

Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration.

Villa C, Ghezzi L, Fenoglio C, Clerici F, Marcone A, Benussi L, Ghidoni R, Gallone S, Serpente M, Cantoni C, Ridolfi E, Bonsi R, Cerami C, Cappa S, Binetti G, Franceschi M, Rainero I, Mariani C, Bresolin N, Scarpini E, Galimberti D.

J Alzheimers Dis. 2012;31(3):537-42. doi: 10.3233/JAD-2012-120379.

PMID:
22614877
17.

Reduced NMDAR1 expression in the Sp4 hypomorphic mouse may contribute to endophenotypes of human psychiatric disorders.

Zhou X, Nie Z, Roberts A, Zhang D, Sebat J, Malhotra D, Kelsoe JR, Geyer MA.

Hum Mol Genet. 2010 Oct 1;19(19):3797-805. doi: 10.1093/hmg/ddq298. Epub 2010 Jul 15.

18.

Confirmed rare copy number variants implicate novel genes in schizophrenia.

Tam GW, van de Lagemaat LN, Redon R, Strathdee KE, Croning MD, Malloy MP, Muir WJ, Pickard BS, Deary IJ, Blackwood DH, Carter NP, Grant SG.

Biochem Soc Trans. 2010 Apr;38(2):445-51. doi: 10.1042/BST0380445.

PMID:
20298200
19.

Transcription factor SP4 is a susceptibility gene for bipolar disorder.

Zhou X, Tang W, Greenwood TA, Guo S, He L, Geyer MA, Kelsoe JR.

PLoS One. 2009;4(4):e5196. doi: 10.1371/journal.pone.0005196. Epub 2009 Apr 9.

20.

Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.

Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, Davies P, Davis KL.

Arch Gen Psychiatry. 1997 Jun;54(6):559-66. Erratum in: Arch Gen Psychiatry 1997 Oct;54(10):912.

PMID:
9193197

Supplemental Content

Loading ...
Support Center